• About
  • Meet The Team
  • Privacy Policy
Monday, March 8, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

The 3 Best Pharmacy Stocks for long-term Investment

by Ali Hassan
February 4, 2021
in Morning News
Share on FacebookShare on Twitter

The pharma industry has been a long-term investment opportunity for investors over the years.

The global pharmaceutical industry is a massive market that continues to grow each year. It is estimated to be more than $1.2 trillion in sales annually. The COVID-19 pandemic has been a massive catalyst in pushing pharma firms to their limit. The majority of the companies have tried their luck in developing the coronavirus vaccine—with several being successful and others under clinical trials.

For investors, the pharmacy stocks have the potential to reap solid long-term results—with a broader market. Especially, with the demand for vaccines high all over the world, the pharma stocks could be making big profits in the future. So, let’s have a look at the three best pharma stocks for long-term investment.

Pfizer (PFE)

Pfizer (PFE) has been the highlight of last year. The US-based pharma firm was the first—in collaboration with BioNTech—to develop the COVID-19 vaccine. Despite the vaccine news, the stock price hasn’t skyrocketed as it was expected. So, there is much upside considering the stock being backed by Pfizer’s vaccine and other top-line products.

Recently, the company reported its fourth-quarter results, with earnings on the lower side as per the expectations. The Q4 2020 adjusted earnings were $0.42 per share, topping by 14% Year-over-Year but missing analysts’ estimate of $0.51 per share. While, the sales increased by 12% to $11.68 billion, missing projected sales of $12.01 billion.

Mizuho Securities analyst Vamil Divan said that the company has multiple parts under movement, but the long-term seems strong with its core assets performing well. Pfizer has reportedly said that they are expecting $15 billion of vaccine sales this year. So far, the company has vaccine sales of around $154 million.

With much happening, Pfizer (PFE) stock is still in the buy range.

Bristol-Myers (BMY)

Bristol Myers Squibb (BMY) is one of the leading pharmaceutical firms in biologics in several therapeutic areas, including cancer. The company is set to release its fourth-quarter results on Feb. 4, 2021.

According to Forbes, the overall outcome is expected to be slightly on the lighter side as per the analysts’ estimate. The quarterly results are affected by a slow sales growth rate of Opdivo. However, the company should see an increase in overall demand due to a rise in hospital visits.

The company has announced that it has obtained positive outcomes from the second pivotal Phase 3 trial for its novel, oral, POETYK PSO-2. Bristol is working on selective tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis—patients with moderate to severe disease. Almost 100 million people are suffering from psoriasis around the world. If the company goes on to successfully market its product, it would bring massive revenue in the longer run.

Furthermore, Bristol Myers Squibb (BMY) has collaborated with The Rockefeller University for the rights to a Covid-19 therapy that combines two antibodies. The company stated that the vaccine variant of Rockefeller has delivered effective results against SARS-CoV-2. So, this deal could be another big plus for Bristol as we head forward.

Anavex (AVXL)

Anavex Life Sciences (AVXL) is a promising biopharma firm that has gained a lot of attention for its lead candidate of Alzheimer’s disease, Anavex 2-73 (A2-73). Recently, the company updated that it has completed 80enrollment for the Phase 2b/3 trials. While the remaining enrollment of 450 patients is anticipated in near-future.

Over the past 12-months, AVXL shares have soared over 163%. As of Feb. 4, in pre-market trading, the stock is up by nearly 87% trading around $19.67. The bullish sentiment is pushed by the lead drug of Anavex.

So far, the data shows that Anavex 2-73 is very effective against Alzheimer’s disease. According to World Health Organization, more than 50 million suffer from dementia—a type of Alzheimer—all over the world. And, around 10 million new cases arise each year.

Being bullish on Anavex, Seeking Alpha’scontributor Lane Simonian stated that Anavex 2-73 has the best chance of long-term success among the rest of the drugs being studied by the company. So, Anavex (AVXL) is a stock to watch for long-term investment.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: AnavexAnavex NewsAnavex StockAnavex Stock ForecastAVXLAVXL NewsAVXL StockAVXL Stock ForecastBMYBMY NewsBMY stockBMY Stock ForecastBristol-MyersBristol-Myers NewsBristol-Myers stockBristol-Myers Stock ForecastPFEPFE NewsPFE stockPFE Stock ForecastPfizer‎Pfizer NewsPfizer Stock‎Pfizer Stock ForecastPharmacy Stocks

Related Posts

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
Morning News

Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

March 8, 2021
Top Gainers Pre-Market as Big Tech Uplifts Markets
Morning News

Is this a bubble or reality: XTL Biopharmaceuticals Ltd (XTLB) stock sky-rocketed in the pre-market session?

March 5, 2021
GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
Morning News

Early Morning Vibes: 4 Top Movers To Watch For Weekend

March 5, 2021
The 3 Best Tech Stocks to Buy Now
Morning News

Watching the Tune: What Happens to Waitr Holdings Inc. [WTRH]

March 5, 2021
GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
Investing

Early Morning Vibes: 4 Hot Stocks You Might Consider For Thursday

March 4, 2021
Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
Morning News

Lipocine Inc. [LPCN] is a stock which investors cannot afford to ignore

March 4, 2021
Next Post
GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020

Organogenesis Holdings (ORGO) Stock trading at 52-week high ‎with strong earnings outlook

VeChain (VET): A Crypto that extends its network across broader markets

VeChain (VET): A Crypto that extends its network across broader markets
by Ali Hassan
March 8, 2021
0

VeChain focuses on sustainable energy and is one of the pioneers in the blockchain industry. VeChain (VET) is one of...

Read more

Early Morning Vibes: Top 4 Stocks To Buy Right Now

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
March 3, 2021
0

US stock indices closed with growth on Monday. The last week rally in US government bond yields stalled, easing investors'...

Read more

The fundamentals of KemPharm Inc. (KMPH) lend themselves to long-term investors

Why IBIO Inc [IBIO] is the Best Covid-19 Vaccine Stock to Bet On
by Hasnain R
March 3, 2021
0

KemPharm, Inc. (NASDAQ: KMPH)has performed -15.80% so far this year, while over the last seven days it has performed -4.8%....

Read more

Best Cryptocurrencies to Watch in 2021

Best Cryptocurrencies to Watch in 2021
by Zoha Fatim
March 8, 2021
0

With the pandemic starting in 2020, cryptocurrency stocks have seen a new interest as the world has started to see...

Read more

SOS Limited (SOS) Stock Surged 18% In After Hours Trading. Here Is The Reason

Is Consumer Portfolio Services (NASDAQ: CPSS) A Good Stock To Buy?
by Shan Zee
March 2, 2021
0

The emergency rescue services technology company SOS Limited (SOS) saw its shares’ price rising 18.39% in trading after the ring...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.